Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

1
Player Avatar fewl10 (< 20) Submitted: 12/14/2008 9:07:11 PM : Underperform Start Price: $24.73 EBS Score: +3.78

Good grief. What a bubble

Featured Broker Partners


Advertisement